FindTrial
Sign In

The Role of microRNA-29b in the Oral Squamous Cell Carcinoma

The Role of microRNA-29b in the Oral Squamous Cell Carcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02009852
Acronym
microRNA-29b
Enrollment
100
Registered
2013-12-12
Start date
2014-01-31
Completion date
Unknown
Last updated
2013-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cancer

Keywords

microRNA-29b, Oral squamous cell carcinoma, migration, prognosis

Brief summary

The Role of microRNA-29b in the Oral Squamous Cell Carcinoma

Detailed description

To find out if there is prognostic value which to the performance of microRNA-29b of oral cancer in Taiwan and provide some reference for future treatment. We anticipate to enroll 100 persons with oral cancer and collect the tissue which was stained for pathological sections over a 3 year period. We also collect the blood and saliva samples from patients and the results along with patient-specific information such as tumor phases, tumor size, lymph node metastasis, cancer metastasis, prognosis and betel nut chewing, smoking and drinking habits and other parameters are statistically analyzed.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Cancer of the oral cavity.

Exclusion criteria

* pregnant woman * refuse the surgery

Design outcomes

Primary

MeasureTime frame
microRNA-29b3 years

Countries

Taiwan

Contacts

Primary ContactShin-Jung Cheng, DDS, MS, PhD
sjcheng56@ntu.edu.tw+886 2 29251733

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026